Trending News

Breakthrough Treatments Are Changing Autoimmune Disease Care

Breakthrough Treatments Are Changing Autoimmune Disease Care

Mar 5, 2026

Rebalancing the Immune system: new treatments for Autoimmune Disease
Autoimmune diseases happen when the immune system gets confused and starts attacking the body instead of protecting it. Conditions like lupus, rheumatoid arthritis, type 1 diabetes, and multiple sclerosis can be lifelong, painful, and hard to control. For decades, most treatments worked by broadly suppressing the immune system, basically turning the volume down on immunity across the board. But now, researchers are moving toward something much more precise. Instead of shutting down the entire immune response, new immunotherapies aim to retrain or rebalance it. The goal isn’t just symptom control, it’s restoring immune balance while keeping normal defenses intact.

A Remarkable Treatment Response in a Rare and Aggressive Form of Endometrial Cancer

A Remarkable Treatment Response in a Rare and Aggressive Form of Endometrial Cancer

Mar 4, 2026

Endometrial cancer is common, but once it spreads or returns after treatment, it becomes very difficult to manage. Clear treatment guidelines are limited, especially for aggressive subtypes like serous endometrial cancer, which grows quickly and often does not respond well to standard therapy. A new case report describes a rare and impressive response to trastuzumab...

Research Results for New Triple-Negative Breast Cancer Combination Treatment

Research Results for New Triple-Negative Breast Cancer Combination Treatment

Mar 2, 2026

What if a new drug combo could finally help patients with the toughest breast cancer?
Triple-negative breast cancer, or TNBC, is one of the most aggressive forms of breast cancer. It’s called “triple negative” because the cancer cells lack three common receptors — estrogen, progesterone, and HER2 — that some other breast cancers have. That matters because most targeted therapies work by attaching to one of those receptors. Without them, TNBC doesn’t respond to hormone therapy or HER2-targeted drugs, so doctors often rely on chemotherapy first. TNBC accounts for about 15–20% of breast cancer cases and is especially hard to treat once it spreads.

Relief During Menopause: The Role of Hormone Replacement Therapy

Relief During Menopause: The Role of Hormone Replacement Therapy

Mar 1, 2026

The effects of menopause can make a woman’s daily life much harder, and therapies approved by the U.S. Food and Drug Administration can help. But too many women might not use these treatments to lessen their menopause symptoms because of the risks associated with these drugs described in the drug labels’ boxed warnings (the FDA’s most prominent warnings). The FDA...

New Labeling Changes Aim to Improve Safety of Menopausal Hormone Therapy

New Labeling Changes Aim to Improve Safety of Menopausal Hormone Therapy

Feb 26, 2026

The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for these drugs. Specifically, risk statements related to cardiovascular disease, breast cancer and probable dementia were removed from the “boxed warning,” the agency’s...

Advancing Cancer Treatment: FDA Authorizes Innovative Pancreatic Cancer Device

Advancing Cancer Treatment: FDA Authorizes Innovative Pancreatic Cancer Device

Feb 24, 2026

The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer. Optune Pax, developed by Novocure, is a portable, non-invasive device that delivers alternating electrical fields, known as tumor treating fields (TTFields), to the abdomen. TTFields work by physically disrupting...